openPR Logo
Press release

Vascular Stent Market -Product Segmentation Overview 2025| Lombard Medical Technologies, Abbott Laboratories

08-24-2018 11:34 AM CET | Health & Medicine

Press release from: TMR Research

/ PR Agency: TMR Research
Vascular Stent Market -Product Segmentation Overview 2025| Lombard Medical Technologies, Abbott Laboratories

Global Vascular Stent Market: Snapshot

The global market for vascular stents has been growing at a robust rate on account of the rising incidence of cardiovascular diseases across the globe. The healthcare industry has been witnessing an overbearing amount of patients who have suffered heart strokes or cardiac arrests. This has paved way for increased demand within the global market for vascular stents. These stents can be useful during angioplasty and work on the coronary arteries. The blockages in the arteries can hamper the blood circulation in the body, and may even lead to sudden death. Due to this reason, it is important effectuate immediate treatment of patients suffering from any form of disorder related to the arteries or the heart.

Request Sample Copy of the Report @
www.tmrresearch.com/sample/sample?flag=B&rep_id=2618

The changing lifestyles of the people and the growing inclination of the masses towards oily or junk food have given rise to several cardiovascular diseases. This has directly contributed to the growth of the global market for vascular stents and has generated growth spaces for market players. Furthermore, the willingness of the healthcare sector to adopt new kinds of stents including drug-eluting stents, bare-metal stents, and bio-absorbable stents has also created tremendous demand within the global market.

The field of cardiology has been witnessing several advancements in recent times, thus, giving an impetus to the growth of the global market for vascular stents. The market for vascular stents has done extremely well across North America on account of the immaculate healthcare industry in the region. Besides this, the high population and unhealthy food habits in India has resulted in an increased incidence of cardiovascular diseases across Asia Pacific.

Global Vascular Stent Market: Overview

As the incidence of peripheral artery disease grows, the global demand for vascular stents is expected to swell as well. Vascular stents are medical devices that are usually placed as part of peripheral artery angioplasty. In simple terms, a stent is a plastic or metal tube that is inserted into an anatomic vessel so as to keep the passageway from closing. Iliac, carotid, and femoral arteries are some common sites which are treated with vascular stents.

Request TOC of the Report @
www.tmrresearch.com/sample/sample?flag=T&rep_id=2618

Global Vascular Stent Market: Key Trends

The growing prevalence of peripheral vascular disease (PVD), which is alternatively known as peripheral artery disease (PAD), is one of the primary growth drivers of the global vascular stents market. According to the U.S. Centers for Disease Control and Prevention (CDC), nearly 8 million in the U.S. alone suffer from peripheral artery disease. Of these, 12 to 20% of the patients are above the age of 60, finds the study. Thus, it has been understood that the geriatric population is at a higher risk of suffering from peripheral artery disease. Since the aging population has been escalating at a rapid pace, the global vascular stent market will witness greater growth.

On the downside, the exorbitant costs of these devices might hinder the growth of the global vascular stent market. However, as a number of market vendors have been developing highly efficient and accurate imaging techniques, the market for vascular stents is likely to receive a boost.

Global Vascular Stent Market: Market Potential

A number of market players are concentrating on the introduction of innovative products, enhancing the ease of use for healthcare providers as well as patients. The researchers at the Technische Universiteit, Eindhoven (Eindhoven University of Technology) have acknowledged the special challenge presented by pediatric patients. The creation of customized stents is not a novel phenomenon. The researchers have produced a relatively better vascular stent, according to an announcement made in May 2017.

The new stent can expand as the child grows, biodegrading with time, as against conventional stents that children outgrow. The traditionally used metal stents can also lead to complications including hyperplasia. In order to design this 3D printable, self-expanding stent, a computational model of a nickel titanium stent was built by the researchers.

Several other products are receiving regulatory approvals. For instance, in the same month, Alucent Medical, Inc. announced that it received the approval of the U.S. Food and Drug Administration (FDA) to commence Phase I human clinical studies of its new drug/device combination therapy for treating peripheral vascular disease.

Global Vascular Stent Market: Regional Outlook

The global vascular stent market can be segmented into Europe, Latin America, North America, the Middle East and Africa, and Asia Pacific. North America has currently been leading the global vascular stent market, with the U.S. as the chief contributor. The growing patient base and rising concentration of geriatric populace have been driving the growth of this region.

Read Comprehensive Overview of Report @
www.tmrresearch.com/vascular-stent-market

Asia Pacific, driven by augmenting acceptance of cutting-edge technologies, is slated to display fastest rate of growth over the forthcoming period. The low costs of manufacturing, presence of a large number of market participants, and growing incidence of cardiovascular diseases have been assisting the growth of the global vascular stent market.

Global Vascular Stent Market: Competitive Analysis

MicroPort Scientific Corporation, Vascular Concepts, Medtronic, plc, B. Braun Melsungen AG, STENTYS SA, Lombard Medical Technologies, Abbott Laboratories, BIOTRONIK SE & Co. KG, Meril Life Sciences Pvt. Ltd., W. L. Gore and Associates, Boston Scientific Corporation, and Endologix, Inc. are some key vendors operating in the global vascular stent market.

About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends. Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vascular Stent Market -Product Segmentation Overview 2025| Lombard Medical Technologies, Abbott Laboratories here

News-ID: 1199505 • Views: 496

More Releases from TMR Research

Farm Animal Drug Market 2025 | Zydus Animal Health Ltd., Zoetis, Inc.
Global Farm Animal Drug Market: Snapshot Farm animal drugs are medicines mainly used for healthcare-based practices for diagnosis, cure, mitigation, treatment, or prevention of diseases that could affect livestock. These medicines need to be used as per strict requirement based on their essentiality to maintain well-being of farm animals. Simply said, farm animal drugs are a key factor supporting the growth of livestock industry all over the globe. Get Sample Copy of
Survey On Innovation: Immune Thrombocytopenia Drugs Market 2028 | Rigel Pharmace …
Immune Thrombocytopenia Drugs Market: Overview The autoimmune disorder of immune thrombocytopenia outcomes in an unusually low level of platelets. Asymptomatic bleeding disorders are immune thrombocytopenia. Only after platelet counts are exceptionally low appear symptoms. These are petechias, skin contusions, bleeding from the rubber gum, among others. While most of the ITP aren’t fatal cases, roughly 3 per cent die from complication like intracranial hemorrhages and infection in chronic refractory ITP patients.
Neglected Tropical Disease Treatment Market Landscape Assessment By Type, Opport …
Global Neglected Tropical Disease Treatment Market: Introduction Relevant issues like sanitation, neatness, and cleanliness still stress a few pieces of the world even today. This outcomes in spike of contaminations and diseases that usually get neglected. They are named as neglected tropical diseases. World Health Organization states that these malady influence almost 1 billion individuals over the globe. This clarifies the upcoming potential for organizations in the global neglected tropical
Business Overview: Uveitis Drugs Market 2028 | Allergan India Private Limited, T …
Global Uveitis Drugs Market: Overview A limited choice of commercial drugs composed of corticosteroid treatments, immunosuppresives and biologics is characteristic of the global uveitis drugs market. Uveitis (Uveitis) is a median eye inflammation (Uvea) known as the uvea tract. The uvea is made up of iris, ciliary and choroids. Certain prevalent causes of uveitis are autoimmune diseases, infection, injury, inflammatory diseases and surgeries. Uveitis-related common symptoms include eye pain, floating

All 26115 Releases


More Releases for Vascular

Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations. Request for Sample of This Research Report @ https://bit.ly/2xjOKpC Top Key Player:- Abbott Laboratories Braun Melsungen AG Boston Scientific Corporation R. Brad, Inc. Cardinal Health, Inc. Medtronic plc. Cook Medical, Inc. Teruma Corporation Jude Medical, Inc. The Spectranetics Corporation Volcano Corporation Peripheral vascular disorder (PVD) is a blood circulation disorder
Stromal Vascular Fraction Market
Prevalence of knee osteoarthritis is expected to provide a significant opportunity to the new class cell therapies to penetrate the market. Moreover, soaring demand for reconstructive breast therapies are also estimated to fuel the market in near future. Among all the clinical trials being conducted for stromal vascular fraction therapeutics, breast reconstruction procedures have reported highest proportion and outcomes for it to appear promising, as per the research conducted by
Global Large Bore Vascular Closure Devices Market 2018 - Abbott Vascular, St. Ju …
Apex Market Reports, recently published a detailed market research study focused on the “Large Bore Vascular Closure Devices Market” across the global, regional and country level. The report provides 360° analysis of “Large Bore Vascular Closure Devices Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the
Vascular Access Devices Market Outlook
Global Vascular Access Devices Market: Snapshot The demand in the global market for vascular access devices, which are medical devices made of hollow and flexible tubes of latex or silicone that enable an access to the bloodstream, has been consistently incrementing owing to growing number of surgeries performed each year across the world. Vascular access devices are used to perform diagnostic tests, reading central venous pressure, blood sampling, blood transfusion, and
Second Generation Vascular Lesion Models
Animal Replacement Technologies announced today the launch of their second-generation arterial lesions. These lesions are more sophisticated that the original chronic total occlusion models, and are designed to integrate with the company\'s current peripheral, coronary, and cerebral vascular products. these may be mounted in straight or branched sections as small as 1mm in diameter, may be softcap or hardcap, chronic total occlusions or characterized by a particular TIMI flow, and
New Vascular Lesion Models
Animal Replacement Technologies announced today the launch of a new line of synthetic vascular lesion products for medical device developers and surgical educators; chronic total occlusion models. Such models are invaluable to the development of products that treat blockages in the peripheral vascular system since there are currently no other repeatable and reliable models available to engineers and scientists that wish to mimic such conditions. Using these new models, which are